Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of ...

CET/CESTThe issuer is solely responsible for the content of this announcement.CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE European Patent ...

Citigroup started coverage on shares of BioNTech (NASDAQ:BNTX – Free Report) in a report issued on Thursday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $145.00 target ...

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

March 5, 2025 Health Rounds: Roche/BioNTech experimental vaccine shows early promise in pancreatic cancer Half of the patients who received an experimental vaccine for pancreas cancer being ...

Genmab A/S, a biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark. The company markets EPKINLY and TEPKINLY for ...

Pfizer and its partner BioNTech, and Moderna ... or to vaccinate at-risk agricultural workers. Last year Finland bought some H5N1 vaccine to offer to workers on fur farms that have experienced ...

Meanwhile, China responded with retaliatory tariffs on U.S. agricultural goods including ... Stocks In Focus: BioNTech SE ADR (NASDAQ:BNTX) slipped 1.06% in premarket on Monday ahead of its ...

In a report released today, Eliana Merle from UBS maintained a Hold rating on BioNTech SE (BNTX – Research Report), with a price target of $115.00. The company’s shares closed yesterday at $105.35.

DUESSELDORF, Germany, March 5 (Reuters) - A German court on Wednesday ruled that Pfizer (PFE.N), opens new tab and its partner BioNTech (22UAy.DE), opens new tab violated a COVID-19 vaccine patent ...

Investing.com -- Shares of BioNTech SE (NASDAQ: NASDAQ:BNTX) fell 3% following news that the U.S. Food and Drug Administration (FDA) placed a clinical hold on the company’s Investigational New ...